Page 25 - JCTR-9-5
P. 25

Journal of Clinical and Translational Research 2023; 9(5): 327-331




                                        Journal of Clinical and Translational Research

                                               Journal homepage: http://www.jctres.com/en/home


        CASE REPORT

        Pancreas sparing duodenal resection in colorectal adenocarcinoma with

        local invasion to the duodenum: a case report and literature review



        Si Ying Adelina Ho , Thomas Zheng Jie Teng *, Vishal G. Shelat 1,2
                                               1,2
                        1
        1 Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore,  Department of General Surgery, Tan Tock Seng Hospital,
                                                                     2
        Singapore
        ARTICLE INFO                        ABSTRACT

        Article history:                    Background: Pancreas sparing duodenal resection (PSDR) is commonly described in patients with
        Received: December 21, 2022         familial duodenal adenomatous polyposis, duodenal gastrointestinal stromal tumors, duodenal trauma,
        Revised: July 11, 2023              or other primary duodenal lesions where the pancreas is not involved. PSDR in patients with metastatic
        Accepted: July 11, 2023             involvement of the duodenum is rarely described. After reviewing the relevant literature, <5 PSDR for
        Published Online: September 23, 2023  duodenal metastases reports were retrieved. Our patient was treated with PSDR for a local recurrence
                                            after a right hemicolectomy was performed for right colon adenocarcinoma a year before.
        Keywords:                           Aim: The aim of the study was to investigate if PSDR is feasible in this patient with recurrence of a
        Colorectal adenocarcinoma           locally advanced right colon adenocarcinoma invading the duodenum.
        Duodenal metastases                 Case Summary: A 74-year-old female patient presented with the right iliac fossa pain and weight loss
        Pancreatic sparing duodenal resection  1-year post-resection of the primary ascending colon cancer. A surveillance computed tomography
        Case study                          scan of the thorax, abdomen, and pelvis showed a mass in the third segment of the duodenum. The
                                            decision to carry out a PSDR was made.
        *Corresponding authors              Results: The proximal and distal margins of the resected bowel were uninvolved by the invasive
        Thomas Zheng Jie Teng               carcinoma and metastasis in five out of 12 regional lymph nodes was found. The post-operative course
        Tan Tock Seng Hospital, 11 Jalan Tan Tock   was complicated by a Grade B post-operative pancreatic fistula but recovered well post-drainage.
        Seng, 308433 Singapore.             Conclusions: PSDR can be utilized in the management of duodenal metastases.
        E‐mail: zteng004@e.ntu.edu.sg       Relevance for Patients: PSDR can be performed in patients with duodenal metastases, offering a
                                            lower morbidity rate as compared to conventional pancreaticoduodenectomy.
        © 2023 Author(s). This is an Open-Access
        article distributed under the terms of the
        Creative Commons Attribution-Noncommercial
        License, permitting all non-commercial use,   1. Introduction
        distribution, and reproduction in any medium,
        provided the original work is properly cited.  The pancreas is an unforgiving organ, and surgery involving  the pancreas carries a
                                            significant risk of morbidity, especially for post-operative pancreatic fistulas (POPF). The
                                            incidence of POPF following distal pancreatectomy or pancreaticoduodenectomy is reported
                                            in up to 30% of patients [1]. Surgeons resort to centralizing pancreatic surgical services,
                                            technical modification of key surgical steps, standardized protocol-driven clinical care, and
                                            pharmacological intervention to reduce the morbidity following pancreatic resections [1,2].
                                            One method of reducing morbidity would be to avoid pancreatic resections in, for example,
                                            duodenal-only  lesions.  This  is  especially  relevant  as  POPF  rates  following  pancreas
                                            resection are higher in patients with a soft pancreas texture and non-dilated pancreatic ducts,
                                            a typical feature of duodenal-only lesions [3,4]. Thus, pancreas-sparing duodenal resection
                                            (PSDR) is an attractive option, and it is no surprise that it is widely reported in patients with
                                            familial duodenal adenomatous polyposis, duodenal gastrointestinal stromal tumors, and a
                                            myriad of other primary duodenal lesions. Preserving the pancreas keeps the endocrine and
                                            exocrine function intact with a low risk of post-pancreatectomy diabetes and alleviates the

                                           DOI: http://dx.doi.org/10.18053/jctres.09.202305.22-00228
   20   21   22   23   24   25   26   27   28   29   30